---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-227478"
form_type: "8-K"
ticker: "KALV"
cik: "0001348911"
company_name: "KalVista Pharmaceuticals, Inc."
filed_at: "2025-10-02T23:59:59+00:00"
generated_at: "2026-05-17T04:54:42.988768+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# KalVista appoints Bethany Sensenig to Board and Audit Committee; annual meeting results filed

## Summary
- Bethany Sensenig appointed to Board and Audit Committee effective October 1, 2025.
- Sensenig is CFO and Head of Operations at Radius Health; former Biogen VP of Finance.
- Nancy Stuart moves off Audit Committee but remains on Board and joins Compensation Committee.
- Stockholders re-elected Benjamin Palleiko and Brian Pereira as Class I directors for three-year terms.
- Advisory vote on named executive officer compensation passed with 33.6M shares for vs 4.0M against.

## SEC filing metadata
- accession: 0001193125-25-227478
- form_type: 8-K
- ticker: KALV
- cik: 0001348911
- company_name: KalVista Pharmaceuticals, Inc.
- filed_at: 2025-10-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348911/000119312525227478/0001193125-25-227478-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348911/000119312525227478/d945945d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-227478
- JSON: https://secwatch.observer/filing/0001193125-25-227478.json
- Plain text: https://secwatch.observer/filing/0001193125-25-227478.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.